FR2991181B1 - Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique - Google Patents

Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique

Info

Publication number
FR2991181B1
FR2991181B1 FR1201589A FR1201589A FR2991181B1 FR 2991181 B1 FR2991181 B1 FR 2991181B1 FR 1201589 A FR1201589 A FR 1201589A FR 1201589 A FR1201589 A FR 1201589A FR 2991181 B1 FR2991181 B1 FR 2991181B1
Authority
FR
France
Prior art keywords
useable
sugar
pharmaceutical
metabolic syndrome
intestinal absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1201589A
Other languages
English (en)
Other versions
FR2991181A1 (fr
Inventor
Bruno Eto
Imar Djibrine Soudy
Youssouf Khayar Mahamoud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1201589A priority Critical patent/FR2991181B1/fr
Publication of FR2991181A1 publication Critical patent/FR2991181A1/fr
Application granted granted Critical
Publication of FR2991181B1 publication Critical patent/FR2991181B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
FR1201589A 2012-06-04 2012-06-04 Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique Expired - Fee Related FR2991181B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1201589A FR2991181B1 (fr) 2012-06-04 2012-06-04 Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1201589A FR2991181B1 (fr) 2012-06-04 2012-06-04 Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique

Publications (2)

Publication Number Publication Date
FR2991181A1 FR2991181A1 (fr) 2013-12-06
FR2991181B1 true FR2991181B1 (fr) 2016-02-19

Family

ID=46826575

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1201589A Expired - Fee Related FR2991181B1 (fr) 2012-06-04 2012-06-04 Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre et utilisable pour soigner le syndrome metabolique

Country Status (1)

Country Link
FR (1) FR2991181B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3042386A1 (fr) * 2015-10-20 2017-04-21 Thomaoglou Constant Nouvelle composition alimentaire hypocholesterolemiante
FR3108036A1 (fr) * 2020-03-11 2021-09-17 Bruno Eto Composition pharmaceutique ou diététique contenant l’extrait aqueux de la lavande et utilisable comme antidiabétique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080199489A1 (en) * 2007-02-16 2008-08-21 Parrinello Vincene M Skin treatment formulations and method

Also Published As

Publication number Publication date
FR2991181A1 (fr) 2013-12-06

Similar Documents

Publication Publication Date Title
EA201591166A1 (ru) Ингибиторы аутотаксина
TN2015000283A1 (fr) Functionalized exendin-4 derivatives
EA201491486A1 (ru) Производные пиперидинопиримидина для лечения вирусных инфекций
CO6551686A2 (es) Inmunoglobinas con dominio variable dual y usos de las mismas
EP2847152A4 (fr) Compositions et méthodes de traitement du syndrome métabolique
EP2827869A4 (fr) Compositions et procédés d'amélioration du bénéfice thérapeutique de l'indirubine et de ses analogues y compris du mésoindigo
EA201401028A1 (ru) Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения
DK2861229T3 (da) Farmaceutisk sammensætning indeholdende nikotinsyre og/eller niko-tinamid og/eller tryptophan til positiv påvirkning af tarmmikrobiataen
EE201300007A (et) Kombineeritud ravimkoostis diabeedi ning ainevahetush„irete raviks
EA201690521A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
WO2012135671A3 (fr) Anticorps monoclonaux contre inhibiteur de la voie du facteur tissulaire (tfpi)
EA201600096A1 (ru) Бензил-1н-пиразол[3,4-b]пиридины и их применение
HK1206623A1 (en) Pharmaceutical compositions and treatment of mastitis
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
EP2701700A4 (fr) Pharmacothérapie pour empêcher des effets indésirables induits par une chimiothérapie et compositions pharmaceutiques, diagnostics, techniques de dépistage et trousses associés
EA201890002A1 (ru) Положительные аллостерические модуляторы мускаринового рецептора м2
DK3079675T3 (da) Farmaceutisk sammensætning indeholdende nikotinsyre og/eller nikotinamid til anvendelse til gavnlig påvirkning af blodlipidniveauer ved modificering af tarmmikrobiataen
DK3098224T3 (da) Pyranochromenyl-phenolderivat og farmaceutisk sammensætning til behandling af metabolisk syndrom eller inflammationssygdom
ITTO20110631A1 (it) Composizione farmaceutica di combinazione e metodi per trattare patologie del sistema genitourinario
EP2866817A4 (fr) Compositions d'andrographis paniculata et procédés de traitement d'addictions
BR112014009536A2 (pt) antígenos derivados de 14-3-3 xitrulinada e usos dos mesmos no diagnóstico de artrite reumatoide
WO2015086838A3 (fr) Composition pharmaceutique contenant des combinaisons de nicotinamide et de 5-acide aminosalicylique pour influencer de manière bénéfique la microbiote intestinale et/ou traiter une inflammation gastrointestinale
EP3027049A4 (fr) Traitement de boissons visant à réduire les effets de constituants nocifs
EA201591216A1 (ru) Композиции, содержащие хондроитина сульфат, протеолитические ферменты и сульфгидрильные соединения для улучшения биодоступности хондроитина сульфата
DK2791684T3 (da) Fremgangsmåder til forebyggelse eller behandling af forstyrrelser ved forøgelse af biotilgængeligheden af jern og relateret farmaceutisk formulering

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20240205